Bio Green Med Solution, INC. (BGMSP) SEC Filings — 2025
45 SEC filings for Bio Green Med Solution, INC. (BGMSP) in 2025.
Filings
- Bio Green Med Solution Narrows Focus, Secures Funding Amid Re-Audit — 10-K/A · Nov 26, 2025
- BGMSP Pivots to Fire Safety, Reports $5M Deconsolidation Gain — 10-Q · Nov 13, 2025
- Bio Green Med Solution Files 8-K: Material Agreement, Equity Sales — 8-K · Nov 6, 2025
- Bio Green Med Solution, Inc. Files 8-K on Asset Deal — 8-K · Oct 7, 2025
- Bio Green Med Solution, Inc. Files 8-K on Officer/Director Changes — 8-K · Sep 25, 2025
- Bio Green Med Solution Files 8-K/A Amendment — 8-K/A · Sep 17, 2025
- Bio Green Med Solution Faces Delisting Notice — 8-K · Sep 16, 2025
- Cyclacel Pharmaceuticals Files 8-K on Asset Deal & Charter Changes — 8-K · Sep 12, 2025
- Cyclacel Pharmaceuticals Files 8-K on Shareholder Votes & Financials — 8-K · Sep 5, 2025
- Cyclacel Pharmaceuticals Files 8-K: Material Agreement & Equity Sales — 8-K · Sep 4, 2025
- Cyclacel Pharmaceuticals Reports Material Definitive Agreement — 8-K · Sep 2, 2025
- Cyclacel Pharmaceuticals Changes Certifying Accountant — 8-K · Aug 28, 2025
- Cyclacel Pharmaceuticals Files Proxy Materials — DEFA14A · Aug 25, 2025
- Cyclacel Narrows Loss Amid Strategic Pivot, Proposed Merger — 10-Q · Aug 14, 2025
- Cyclacel Pharmaceuticals Files 8-K — 8-K · Aug 13, 2025
- Cyclacel Amends S-1 for Continuous Offering, Shifts HQ to Malaysia — S-1/A · Jul 31, 2025
- Cyclacel Pharmaceuticals Files 8-K — 8-K · Jul 28, 2025
- Cyclacel Files S-1 for Continuous Offering, Signals Capital Raise — S-1 · Jul 24, 2025
- Cyclacel Pharmaceuticals Files 8-K — 8-K · Jul 16, 2025
- Cyclacel Pharmaceuticals Files 8-K Report — 8-K · Jul 7, 2025
- Cyclacel Pharmaceuticals Files 8-K with Corporate Updates — 8-K · Jul 2, 2025
- Cyclacel Pharmaceuticals Files 8-K on June 30, 2025 — 8-K · Jun 30, 2025
- Cyclacel Pharma Executive Compensation Details Revealed — DEFA14A · Jun 25, 2025
- Cyclacel Pharmaceuticals Files 8-K with Key Corporate Updates — 8-K · Jun 20, 2025
- Cyclacel Pharmaceuticals Changes Address — 8-K · Jun 3, 2025
- Cyclacel Pharmaceuticals Files 8-K on Financials — 8-K · May 15, 2025
- Cyclacel Pharmaceuticals Files Q1 2025 10-Q — 10-Q · May 14, 2025
- Cyclacel Pharmaceuticals Files 8-K with Bylaw Amendments — 8-K · May 7, 2025
- Cyclacel Pharmaceuticals Files 8-K Report — 8-K · May 6, 2025
- Cyclacel Pharmaceuticals Files S-1 for Securities Registration — S-1 · Apr 25, 2025
- Cyclacel Pharmaceuticals Files 8-K — 8-K · Apr 25, 2025
- Cyclacel Pharma Files DEF 14A on Exec Comp & Stock Awards — DEF 14A · Apr 24, 2025
- Cyclacel Pharmaceuticals Changes Principal Executive Offices — 8-K · Apr 21, 2025
- Cyclacel Pharmaceuticals Files 8-K: Operations, Officers, Financials — 8-K · Apr 2, 2025
- Cyclacel Pharmaceuticals Files 2024 10-K, Details Warrant Activity — 10-K · Apr 2, 2025
- Cyclacel Pharmaceuticals Files 8-K with Key Corporate Updates — 8-K · Mar 24, 2025
- Cyclacel Pharmaceuticals Files 8-K on Key Agreements and Acquisitions — 8-K · Mar 14, 2025
- Cyclacel Pharmaceuticals Files 8-K: Delisting Notice, Control Change — 8-K · Feb 27, 2025
- Cyclacel Pharmaceuticals Files 8-K: Material Agreement & Exhibits — 8-K · Feb 24, 2025
- Cyclacel Pharmaceuticals Files 8-K on Security Holder Rights — 8-K · Feb 12, 2025
- Cyclacel Pharmaceuticals Files 8-K with Key Corporate Updates — 8-K · Feb 6, 2025
- Cyclacel Pharmaceuticals Files 8-K: Other Event — 8-K · Feb 5, 2025
- Cyclacel Pharma Files 2025 Proxy Statement — DEF 14A · Jan 21, 2025
- Cyclacel Pharmaceuticals Files 8-K Report — 8-K · Jan 10, 2025
- Cyclacel Pharmaceuticals 8-K: Agreements, Equity Sales, Officer Changes — 8-K · Jan 6, 2025